<code id='597124C882'></code><style id='597124C882'></style>
    • <acronym id='597124C882'></acronym>
      <center id='597124C882'><center id='597124C882'><tfoot id='597124C882'></tfoot></center><abbr id='597124C882'><dir id='597124C882'><tfoot id='597124C882'></tfoot><noframes id='597124C882'>

    • <optgroup id='597124C882'><strike id='597124C882'><sup id='597124C882'></sup></strike><code id='597124C882'></code></optgroup>
        1. <b id='597124C882'><label id='597124C882'><select id='597124C882'><dt id='597124C882'><span id='597124C882'></span></dt></select></label></b><u id='597124C882'></u>
          <i id='597124C882'><strike id='597124C882'><tt id='597124C882'><pre id='597124C882'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:755
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          FDA poised to publish guidelines for clinical trial diversity
          FDA poised to publish guidelines for clinical trial diversity

          AdobeTheFoodandDrugAdministrationispoisedtotelldrugandmedicaldevicemakershowtobetterincludepeopleofc

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Pfizer, Moderna say biotech, pharma drug development is a sprint

          Fromlefttoright,STAT'sDamianGarde;MikaelDolsten,chiefscientificofficerofPfizerresearchanddevelopment